SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001854270-22-000028
Filing Date
2022-09-01
Accepted
2022-08-31 17:46:10
Documents
14
Period of Report
2022-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K snti-20220831.htm   iXBRL 8-K 50055
2 EX-10.1 a202208318kex101.htm EX-10.1 466211
3 EX-10.2 a202208318kex102.htm EX-10.2 145872
  Complete submission text file 0001854270-22-000028.txt   926087

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20220831.xsd EX-101.SCH 1902
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20220831_lab.xml EX-101.LAB 24831
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20220831_pre.xml EX-101.PRE 13043
8 EXTRACTED XBRL INSTANCE DOCUMENT snti-20220831_htm.xml XML 11295
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 221219015
SIC: 2836 Biological Products, (No Diagnostic Substances)